Health/Long-Term Care
This initiative identifies the major risks that people face as they approach retirement, understands their perceptions of those risks, measures the potential harm from the risks, and evaluates ways to mitigate the risks. Examples of major risks include longevity, health, market, inflation, family, and policy. The CRR gratefully acknowledges Jackson National Life Insurance Company for…
The drug companies want $26,500 per year for the newest Alzheimer’s drug; negotiations might take it to $20,000. The potential for full Food and Drug Administration approval of the new Biogen-Esai Alzheimer’s drug (Leqembi) means that Medicare may make the drug available to beneficiaries. The $26,500 annual price tag associated with Leqembi will wreak havoc wit…
